COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,702 Articles (22,913 medRxiv, 8,789 bioRxiv)

Most recent first Previous |  Page 1481: Articles 14801-14810  | Next

Immunological features that determine the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
Kageyama, T., Tanaka, S., Etori, K., Hattori, K., Miyachi, K., Kasuya, T., Iwamoto, T., Ikeda, K., Igari, H., Yokote, K., Nakajima, H.
10.1101/2021.06.21.449182 — Posted: 2021-06-21
SARS-CoV-2 activates ER stress and Unfolded protein response
Rosa-Fernandes, L., Lazari, L. C., Macedo-da-Silvia, J., Gomes, V. d. M., Machado, R. R. G., dos Santos, A. F., Araujo, D. B., Coutinho, J. V. P., Arini, G. S., Angeli, C. B., de Souza, E. E., Wrenger, C., Marinho, C. R. F., Oliveira, D. B. L., Durigon, E. L., Labriola, L., Palmisano, G.
10.1101/2021.06.21.449284 — Posted: 2021-06-21
Role of physiotherapy team in critically ill COVID-19 patients pronation: can a multidisciplinary management reduce the complications rate?
Glotta, A., Faldarini, N., Biggiogero, M., Saporito, A., Olivieri, D., Molteni, C., Petazzi, S., Mauri, R., Capdevila, X., Ceruti, S.
10.1101/2021.06.20.21258949 — Posted: 2021-06-21
Plasma gradient of soluble urokinase-type plasminogen activator receptor is linked to pathogenic plasma proteome and immune transcriptome and stratifies outcomes in severe COVID-19
Sarif, J., Raychaudhuri, D., D'Rozario, R., Bandopadhyay, P., Singh, P., Mehta, P., Hoque, M. A., Sinha, B. P., Kushwaha, M., Sahni, S., Devi, P., Chattopadhyay, P., Paul, S. R., Ray, Y., Chaudhuri, K., Banerjee, S., Majumdar, D., Saha, B., Sharma Sarkar, B., Bhattacharya, P., Chatterjee, S., Paul, S., Ghosh, P., Pandey, R., Sengupta, S., Ganguly, D.
10.1101/2021.06.19.21259125 — Posted: 2021-06-21
Excellent negative predictive value (99.8%) of two rapid molecular COVID-19 tests compared to conventional RT-PCR for SARS-CoV-2 (COVID-19) in 2,011 tests performed in a single centre.
Leong, K. W., Law, T. L., Saiful, A. b. S., Kang, C. C., Woo, Y. Y., Chow, T. S., Yong, Z. L.
10.1101/2021.06.20.21258392 — Posted: 2021-06-21
Rapid displacement of SARS-CoV-2 variant B.1.1.7 by B.1.617.2 and P.1 in the United States
Bolze, A., Cirulli, E. T., Luo, S., White, S., Cassens, T., Jacobs, S., Nguyen, J., Ramirez, J. M., Sandoval, E., Wang, X., Wong, D., Becker, D., Laurent, M., Lu, J., Isaksson, M., Washington, N. L., Lee, W.
10.1101/2021.06.20.21259195 — Posted: 2021-06-21 Discussion: Onsite
Increased Risk of Severe COVID-19 Disease in Pregnancy in a Multicenter Propensity Score-Matched Study.
Cojocaru, L., Noe, M., Pahlavan, A., Werzen, A., Seung, H., Yoo, Y. C. J., Tyson, P., Narayanan, S., Turan, S., Turan, O. M., Chua, J. V.
10.1101/2021.06.18.21258899 — Posted: 2021-06-21
Poliovirus Vaccination Induces a Humoral Immune Response that Cross Reacts with SARS-CoV-2
Comunale, B. A., Engineer, L., Jiang, Y., Andrews, J. C., Liu, Q., Ji, L., Yurkovich, J. T., Comunale, R. A., Xie, Q.
10.1101/2021.06.19.21257191 — Posted: 2021-06-21 Discussion: Onsite
Screening for the alpha variant of SARS-CoV-2 (B.1.1.7) and the impact of this variant on circulating biomarkers in hospitalised patients
braybrook, e., Pandey, S., Vryonis, E., Anderson, N. R., Young, L., grammatopoulos, d.
10.1101/2021.06.18.21258699 — Posted: 2021-06-21
REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant
Riley, S., Walters, C. E., Wang, H., Eales, O., Haw, D., Ainslie, K. E. C., Atchinson, C., Fronterre, C., Diggle, P. J., Page, A. J., Prosolek, S. J., Trotter, A. J., Thanh, L. V., Alikhan, N.-F., Jackson, L. M., Ludden, C., The COVID-19 Genomics UK (COG-UK) Consortium, , Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.06.17.21259103 — Posted: 2021-06-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).